Dr. Christopher Thomas Stokoe, MD
- Medicare services, 2024
- 53,084
- Medicare patients, 2024
- 839
- Part D claims, 2024
- 1,110
- Publications
- 7
- Clinical trials
- 10
- Practice address
- 3705 W 15th St, Plano, TX 75075
- Practice phone
- Call (972) 997-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Texas Oncology PA
Plano, Texas
Find Dr. Stokoe's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Christopher Thomas Stokoe is a medical oncologist in Plano, Texas
Dr. Stokoe practices at Texas Oncology PA in Plano, Texas.
Dr. Stokoe's NPI, 1801839758, was assigned on June 14, 2006. Dr. Stokoe graduated from University of Texas Medical Branch School of Medicine in 1996. Dr. Stokoe holds Texas license K2805.
- NPI
- 1801839758NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6103729413
- NPI enumeration date
- June 14, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (972) 997-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Christopher Thomas Stokoe practices at Texas Oncology PA in Plano, Texas
Dr. Stokoe's primary practice is Texas Oncology PA, at 3705 W 15th St, Plano, TX 75075 in Collin County. The practice phone is (972) 997-8000.
- Texas Oncology PA3705 W 15th St, Plano, TX 75075 · Collin CountyPhone(972) 997-8000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Christopher Thomas Stokoe is affiliated with 9 sites of care and 1 medical group
Dr. Stokoe's primary practice is Texas Oncology PA in Plano, Texas. Dr. Stokoe is also affiliated with Medical City Plano Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Stokoe to 5 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Christopher Thomas Stokoe's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stokoe practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Texas Oncology PA | Available with a free account |
| +8 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Christopher Thomas Stokoe is one of 484 medical oncologists in Texas
Medical oncology is Dr. Stokoe's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Stokoe is board certified in medical oncology by the American Board of Internal Medicine. Dr. Stokoe is licensed in Texas.
Specialties and state licenses
- Medical oncology, TexasPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Stokoe treats.
Medical oncologists near Dr. Stokoe
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Christopher Thomas Stokoe billed Medicare for 53,084 services in 2024
CMS data shows 53,084 Medicare services from Dr. Stokoe across 56 procedure codes in 2024, for 839 Medicare patients. Medicare paid $722,950 for them.
Dr. Stokoe's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 43,5652024: 38,53212%
- Other services
- 2023: 6,9892024: 8,52722%
- Lab and pathology
- 2023: 3,0862024: 2,8448%
- Tests and treatments
- 2023: 1,1272024: 1,0903%
- Surgery
- 2023: 1,0402024: 9578%
- Office and hospital visits
- 2023: 8102024: 8525%
- Imaging
- 2023: 3272024: 28214%
Where Dr. Stokoe's Medicare services took place, 2024
- In an office53,066100%
- In a facility180%
Dr. Stokoe compared with the Texas median for medical oncologists, 2024
- Dr. Stokoe
- Texas median
- Medicare services
- 53,084vs 73672.1 times
- Medicare patients
- 839vs 2004.2 times
- Part D claims
- 852vs 3342.6 times
Medians across 448 medical oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Stokoe's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Stokoe?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Stokoe and other medical oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Christopher Thomas Stokoe treated 839 Medicare patients in 2024, average age 76
CMS counts 839 Medicare patients who saw Dr. Stokoe in 2024. The largest group is 75 to 84, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Stokoe's median patient age at 70, with 78% women.
Dr. Stokoe's Medicare patients by age, 2024
Dr. Stokoe's Medicare patients by sex, 2024
- Women60872%
- Men23128%
Chronic conditions among Dr. Stokoe's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer64%
- Arthritis49%
- Chronic kidney disease29%
- Diabetes29%
- Ischemic heart disease29%
- Anxiety25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Stokoe's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women78%
- Men19%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Christopher Thomas Stokoe wrote 1,110 Medicare Part D claims in 2024
In 2024, Dr. Stokoe wrote 1,110 Medicare Part D claims for 247 patients. 85% of them were for generic drugs. CMS names the drug for 852 of them, across 29 drugs with 11 or more claims each, at $1,019,801 in total drug cost. In 2023, CMS named 913 claims across 27 drugs.
Dr. Stokoe's Part D claims by kind of drug, 2024
- Generic942 claims85%
- Brand-name168 claims15%
Dr. Stokoe's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Stokoe's Part D claims, 2024
- Opioids10%113 of 1,110 claims
- Antibiotics3%31 of 1,110 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9132024: 8527%
Drugs named by CMS: 29 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Christopher Thomas Stokoe scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Stokoe for performance year 2024, reported through an alternative payment model (APM). Dr. Stokoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stokoe as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Stokoe's MIPS scores, performance year 2024
- 85of 100Final score
- 67.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Christopher Thomas Stokoe has 7 publications on record
Dmand AI links 7 papers to Dr. Stokoe, published from 2013 to 2021. 2015 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Chemotherapy, Adjuvant. Dr. Stokoe's most frequent co-authors are Joyce Ann O'Shaughnessy, MD, Joanne Lorraine Blum, MD and Virginia F. Borges, MD.
Dr. Stokoe's papers by year, 2013 to 2021
Topics Dr. Stokoe writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Chemotherapy, Adjuvant
- Cyclophosphamide
- Docetaxel
- Doxorubicin
- Receptor, ErbB-2
- Taxoids
Dr. Stokoe's most frequent co-authors
- Joyce Ann O'Shaughnessy, MD3 shared papers
- Joanne Lorraine Blum, MD2 shared papers
- Virginia F. Borges, MD2 shared papers
Recent publications by Dr. Stokoe
See who Dr. Stokoe researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Stokoe works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Christopher Thomas Stokoe has worked on 10 clinical trials
Dmand AI links Dr. Stokoe to 10 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Stokoe that name 2 trials.
Clinical trials with Dr. Stokoe by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Stokoe's trials
- Breast Neoplasms
- Breast Diseases
- Brain Neoplasms
- Hereditary Sensory and Autonomic Neuropathies
- Neoplasm Metastasis
Investigators on the most trials with Dr. Stokoe
- Philip Abraham Kovoor, MD5 shared trials
- Michaela L. Tsai, MD5 shared trials
- Margaret Block, MD4 shared trials
Recent clinical trials with Dr. Stokoe
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd (opens in a new tab)
The Circulating Cell-free Genome Atlas Study (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Christopher Thomas Stokoe received $89,260 in industry payments from 2016 to 2025
CMS Open Payments shows 287 general payments to Dr. Stokoe from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Puma Biotechnology, Inc. paid the most, $70,821. It also lists 3 research payments totaling $12,437 from 2018 to 2019, naming 2 clinical trials.
General payments to Dr. Stokoe by program year, 2016 to 2025
General payments to Dr. Stokoe by kind, 2016 to 2025
- Speaker and faculty fees$54,85061%
- Consulting fees$23,63326%
- Food and beverage$6,7638%
- Travel and lodging$3,7864%
- Education$2290%
Companies that paid Dr. Stokoe the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Christopher Thomas Stokoe has 1 award and honors on record
Dmand AI lists 1 award for Dr. Stokoe, most recently CMS Stage 1 2012 in 2012.
Awards and honors for Dr. Stokoe
- 2012
- CMS Stage 1 2012
Source: Dmand AI Professional Profile Data
Dr. Christopher Thomas Stokoe graduated from University of Texas Medical Branch School of Medicine
Dr. Stokoe graduated from University of Texas Medical Branch School of Medicine in 1996.
- Medical school
- Board certified in medical oncology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Christopher Thomas Stokoe accepts plans from 24 insurance carriers
Dr. Stokoe is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.
- Elevance
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Cigna
- HCSC
- Alliant Health Plans
- +16 more carriersWith a free account
Plan types Dr. Stokoe accepts, by number of carriers
- PPO15
- HMO13
- Medicare12
- POS7
- EPO5
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Christopher Thomas Stokoe's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Christopher Thomas Stokoe
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Christopher Thomas Stokoe's NPI number?
Dr. Christopher Thomas Stokoe's NPI number is 1801839758. It was assigned on June 14, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Christopher Thomas Stokoe?
Dr. Christopher Thomas Stokoe is a medical oncologist in Plano, Texas. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Christopher Thomas Stokoe practice?
Dr. Stokoe practices at 3705 W 15th St, Plano, TX 75075. Dr. Stokoe's primary practice is Texas Oncology PA in Plano, Texas. Dmand AI also links Dr. Stokoe to 5 hospitals, 1 group practice or clinic and 1 home health agency.
What is Dr. Christopher Thomas Stokoe's office phone number?
The practice phone on file for Dr. Stokoe is (972) 997-8000.
What is Dr. Christopher Thomas Stokoe's medical license number?
Dr. Stokoe holds Texas license K2805.
Which hospitals is Dr. Christopher Thomas Stokoe affiliated with?
Dr. Stokoe is affiliated with Medical City Plano Hospital. Dmand AI links Dr. Stokoe to 5 more hospitals.
What medical group is Dr. Christopher Thomas Stokoe part of?
Dr. Stokoe is linked to Texas Oncology.
Does Dr. Christopher Thomas Stokoe accept Medicare?
Yes. CMS data shows Dr. Stokoe billed Medicare for 53,084 services in 2024, and Dr. Stokoe accepts Medicare assignment.
Does Dr. Christopher Thomas Stokoe offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Stokoe as offering telehealth services.
What is Dr. Christopher Thomas Stokoe's MIPS score?
Dr. Stokoe's MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Christopher Thomas Stokoe see?
CMS counts 839 Medicare patients who saw Dr. Stokoe in 2024, with an average age of 76.
Is Dr. Christopher Thomas Stokoe board certified?
Yes. Dr. Stokoe is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Christopher Thomas Stokoe bill to Medicare?
In 2024, Dr. Stokoe's most billed Medicare services were injected or infused drug (J1756), injected or infused drug (J0881) and medicare temporary code (Q9967).
Where did Dr. Christopher Thomas Stokoe go to medical school?
Dr. Stokoe graduated from University of Texas Medical Branch School of Medicine in 1996.
What drugs does Dr. Christopher Thomas Stokoe prescribe most?
In 2024 Medicare Part D data, Dr. Stokoe's most prescribed drugs by claims were Anastrozole, Letrozole and Gabapentin.
Has Dr. Christopher Thomas Stokoe received payments from drug or device companies?
CMS Open Payments shows $89,260 in general payments to Dr. Stokoe from 48 companies from 2016 to 2025. The largest total came from Puma Biotechnology, Inc.
How long has Dr. Christopher Thomas Stokoe been practicing?
Dr. Stokoe graduated from medical school in 1996, 30 years ago.
Does Dr. Christopher Thomas Stokoe do research?
Dmand AI links 7 publications to Dr. Stokoe, published from 2013 to 2021. Dr. Stokoe has worked on 10 clinical trials.
Who does Dr. Christopher Thomas Stokoe publish with?
Dr. Stokoe's most frequent co-authors are Joyce Ann O'Shaughnessy, MD (3 shared papers), Joanne Lorraine Blum, MD (2 shared papers) and Virginia F. Borges, MD (2 shared papers).
What insurance does Dr. Christopher Thomas Stokoe accept?
Dr. Stokoe is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card